A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2054-7064
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences ; volume:6 ; number:1 ; day:13 ; month:5 ; year:2020 ; pages:1-11 ; date:12.2020
Asthma Research and Practice ; 6, Heft 1 (13.5.2020), 1-11, 12.2020
- Creator
-
Kotisalmi, Emma
Hakulinen, Auli
Mäkelä, Mika
Toppila-Salmi, Sanna
Kauppi, Paula
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40733-020-00055-9
- URN
-
urn:nbn:de:101:1-2020072022074048028230
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kotisalmi, Emma
- Hakulinen, Auli
- Mäkelä, Mika
- Toppila-Salmi, Sanna
- Kauppi, Paula
- SpringerLink (Online service)
Other Objects (12)
Correction to: A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Real-life cost-effectiveness of benralizumab in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
P74 - Brittle asthma: a clinical phenotype of severe asthma
Severe asthma and quality of life
Impact of a digital web-based asthma platform, a real-life study
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Severe asthma in childhood
"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic
Patients with Severe Uncontrolled Asthma: Perception of Asthma Control and its Management
Correction to: A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Real-life cost-effectiveness of benralizumab in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
P74 - Brittle asthma: a clinical phenotype of severe asthma
Severe asthma and quality of life
Impact of a digital web-based asthma platform, a real-life study
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Severe asthma in childhood
"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic
Patients with Severe Uncontrolled Asthma: Perception of Asthma Control and its Management
Correction to: A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Real-life cost-effectiveness of benralizumab in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
P74 - Brittle asthma: a clinical phenotype of severe asthma
Severe asthma and quality of life
Impact of a digital web-based asthma platform, a real-life study
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Severe asthma in childhood
"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic